The drug costing more than cancer treatment: Why 29% of employees would switch jobs to get it
GLP-1 cost pressure is now a talent retention issue. A new study found that 29% of employees would switch jobs for coverage, but these drugs aren’t cheap for employers.
The post The drug costing more than cancer treatment: Why 29% of employees would switch jobs to get it appeared first on HR Executive.



